Skip to main content

The Physiological Relevance of Protein Phosphatase 1 and its Interacting Proteins to Health and Disease

Buy Article:

$63.00 plus tax (Refund Policy)

Abstract:

Protein phosphorylation is a major regulatory mechanism of signal transduction cascades in eukaryotic cells, catalysed by kinases and reversed by protein phosphatases (PPs). Sequencing of entire genomes has revealed that ∼37percnt; of all eukaryotic genes encode kinases or PPs. Surprisingly, there appear to be 2-5 times fewer PPs than kinases. Over the past two decades it has become apparent that the diversity of Ser/Thr-specific PPs (STPP) was achieved not only by the evolution of new catalytic subunits, but also by the ability of a single catalytic subunit to interact with multiple interacting proteins. PP1, a STPP, is involved in the control of important cellular mechanisms. Several isoforms of PP1 are known in mammals: PP1α, PP1β and PP1γ . The various isoforms are highly similar, except for the N- and C-termini. The current view is that since PPs possess exquisite specificities in vivo, the key control mechanism must reside in the nature of the PP1 Interacting Protein (PIP) to which they bind. An increasing number of PIPs have been identified that are responsible for regulating the catalytic activity of PPs. Indeed, the diversity of such PIPs explains the need for relatively few catalytic subunit types, and makes them attractive targets for pharmacological intervention. This review will summarize the PIPs identified using the Yeast Two Hybrid methodology and alternative techniques, for instance bioinformatic and proteomic approaches. Further, it compiles 129 PP1-PIP relevant physiological interactions that are well documented in the literature. Finally, the use of PIPs as therapeutic targets will be addressed.





Keywords: ASON; Alpha-synuclein; Alzheimer's disease; Cantharidin; EGFR; Epithermal Growth Factor Receptors; HDACs; Histone deacetylases; PDGFR; PIP; PP1 Interacting Protein; PPs; PSM; Platelet-Derived Growth Factor Receptors; Prostate-specific membrane antigen; Protein kinase; Protein phosphorylation; RVxF motif; SILK motif; STPP; Ser/Thr-specific PPs; Tau protein phosphatase; VEGFR; Vascular Endothelial Growth Factor Receptors; cancer; drug target; fostriecin; glycogen synthase kinase; interactome; microcystin-Sepharose chromatography; protein kinase C; protein phosphatases; regulation; signal transduction; yeast two hybrid

Document Type: Research Article

DOI: https://doi.org/10.2174/092986710793205363

Publication date: 2010-01-01

More about this publication?
  • Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more